source
- Europe’s share of clinical trials falls 13.5% as Asia’s research footprint expandsThe latest data show a 13.5% drop in the number of clinical trials authorized in the EU and EEA compared with pre-pandemic levels. At the same time, Asian countries have increased their share of g…
- Merck's diabetic eye-disease drug hits primary goal but faces commercial doubtsMerck announced results from a pivotal trial of its ophthalmology candidate remigromig, aimed at treating diabetic macular edema. The study achieved its primary endpoint, demonstrating that remigr…